YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
YiChang HEC ChangJiang Pharmaceutical Co Ltd
Operating Income
YiChang HEC ChangJiang Pharmaceutical Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Y
|
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
|
Operating Income
¥2.9B
|
CAGR 3-Years
60%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Income
¥787.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
See Also
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Operating Income?
Operating Income
2.9B
CNY
Based on the financial report for Dec 31, 2023, YiChang HEC ChangJiang Pharmaceutical Co Ltd's Operating Income amounts to 2.9B CNY.
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
22%
Over the last year, the Operating Income growth was 145%. The average annual Operating Income growth rates for YiChang HEC ChangJiang Pharmaceutical Co Ltd have been 60% over the past three years , 22% over the past five years .